Trials / Completed
CompletedNCT04162821
Study on Pharmacokinetics of Hydronidone
Clinical Pharmacokinetics of Hydroxynitone Capsules in Healthy Chinese Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- Beijing Continent Pharmaceutical Co, Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
To evaluate the pharmacokinetic characteristics of hydronidone capsules (specification: 30 mg/ pill) in healthy subjects And the effect of feeding on pharmacokinetics to provide evidence for phase II/III clinical trial protocols.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Hydronidone | Take hydroxynitone capsule |
Timeline
- Start date
- 2019-10-30
- Primary completion
- 2019-11-27
- Completion
- 2021-03-01
- First posted
- 2019-11-14
- Last updated
- 2021-03-24
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04162821. Inclusion in this directory is not an endorsement.